PAR-1 antagonists (Cue Biotech)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePAR-1 antagonists (Cue Biotech)

Drug Alias Nameangiogenesis inhibitor (Cue Biotech)Protease activated receptor 1 antagonist (Cue Biotech)angiogenesis inhibitor (Cue Biotech)angiogenesis inhibitor (cue biotech)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtease-activated receptor-1 antagonists

TargetsProtease-activated receptor-1

Therapy Area/IndicationsInflammationDiabetic RetinopathyNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCaden Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCaden Biosciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationDiabetic RetinopathyNeoplasms

Other Information

ATC CodeN/A